Renal failure and renal replacement therapy

Critical Care Clinics

Volumn 19, Issue 3, 2003, Pages 563-575

  Maxvold, Norma J ^a   Bunchman, Timothy E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BICARBONATE; CITRIC ACID; HYPERTENSIVE AGENT; LACTIC ACID;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; BLOOD FILTRATION; CONTINUAL RENAL REPLACEMENT THERAPY; DIALYSIS; DIALYSIS MEMBRANE; FLUID THERAPY; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; NUTRITION; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SEPSIS;

EID: 0037630383     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(03)00010-1     Document Type: Review

References (56)

1. Warady B, Bunchman T. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000;15:11-3.
2. Lowrie L. Renal replacement therapies in pediatric multiorgan dysfunction syndrome. Pediatr Nephrol 2000;14:6-12.
3. Bunchman T, McBryde K, Mottes T, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 2001;16:1067-71.
4. Goldstein S, Currier H, Graf J, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001;107(6):1309-12.
5. Andreoli SP. Acute renal failure. Curr Opin Pediatr 2002;14(2):183-8.
6. Wong W, McCall E, Anderson B, et al. Acute renal failure in the paediatric intensive care unit. N Z Med J 1996;109:450-61.
7. Mogal NE, Brocklebank JT, Meadow SR. A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 1998;49:91-5, 1998.
8. Menster M, Bunchman TE. Nephrology in the pediatric intensive care unit. Semin Nephrol 1998;18(3):330-40.
9. Parekh RS, Bunchman TE. Dialysis support in the pediatric intensive care unit. Adv Ren Replace Ther 1996;3(4):326-36.
10. Flynn J. Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 2002;17:63-9.
11. Bunchman TE. Acute peritoneal dialysis in infant renal failure. Perit Dial Int 1996;16(Suppl 1):S509-11.
12. Maxvold NJ, Smoyer WE, Gardner JJ, et al. Management of acute renal failure in the pediatric patient: hemofiltration versus hemodialysis. Am J Kidney Dis 1997;30(5 Suppl 4):S84-8.
13. Ronco C, Brendolan A, Bragantini L, et al. Treatment of acute renal failure in the newborn by continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1985;31:634-8.
14. Schuerer DH, Brophy PD, Maxvold NJ, et al. High-efficiency dialysis for Carbamazepine overdose. J Toxicol Clin Toxicol 2000;38(3):321-3.
15. Bunchman TE, Valentini RP, Gardner J, et al. Treatment of vancomycin overdose using high-efficiency dialysis membranes. Pediatr Nephrol 1999;13:773-4.
16. Brophy PD, Tenebein M, Gardner J, et al. Childhood diethylene glycol poisoning treated with alcohol dehydrogenase inhibitor Fomepizole and hemodialysis. Am J Kidney Dis 2000;35(5):958-62.
17. Meyer RJ, Flynn JT, Brophy PD, et al. Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children. Am J Kidney Dis 2001;37(5):1044-7.
18. Bunchman TE, Donckerwolcke RA. Continuous arterial-venous diahemofiltration and continuous veno-venous diahemofiltration in infants and children. Pediatr Nephrol 1994;8(1):96-102.
19. Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001;(Suppl 5):16:67-72.
20. Bunchman TE, Maxvold NJ, Kershaw DB, et al. Continuous venovenous hemodiafiltration in infants and children. Am J Kidney Dis 1995;25(1):17-21.
21. Maxvold NJ, Smoyer WE, Custer JR, et al. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000;28(4):1161-5.
22. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Eng J Med 1994;331:1338-42.
23. Brophy PD, Mottes TA, Kudelka TL, et al. AN-69 membrane reactions are pH-dependent and preventable. Am J Kid Dis 2001;38(1):173-8.
24. Barenbrock M, Hausberg M, Matzkies F, et al. Effects of bicarbonate and lactate buffered replacement fluids on cardiovascular outcome n CVVH patients. Kidney Int 2000;4:1751-7.
25. Bunchman TE, Maxvold NJ, Barnett J, et al. Pediatric hemofiltration: Normocarb® dialysate solution with citrate anticoagulation. Pediatr Nephrol 2002;17:150-4.
26. Clark WR, Mueller BA, Kraus MA, et al. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997;8:804-12.
27. Briglia A, Paganini E. Acute renal failure in the intensive care unit: therapy overview, patient risk stratification, complications of renal replacement, and special circumstances. Intensive Care Complications 1999;20(2):347-66.
28. Swartz R, Messana J, Orzol S, et al. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 1999;34(3):424-32.
29. Mehta RL, McDonald BR, Aguilar MM, et al. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-81.
30. Tolwani A, Campbell R, Schenk M, et al. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-4.
31. Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001;29:1910-5.
32. Kellum J, Angus D, Johnson J, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002;28:29-37.
33. Clermont G, Acker CG, Angus DC, et al. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002;62(3):986-96.
34. Clermont G, Angus DC, Linde-Zwirble WT, et al. Does acute organ dysfunction predict patient-centered outcomes? Chest 2002;121:1963-71.
35. Tremblay R, Ethier J, Querin S, et al. Veno-venous continuous renal replacement therapy for burned patients with acute renal failure. Burns 2000;26(7):638-43.
36. Mehta R, McDonald B, Gabbal F, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60:1154-63.
37. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000;356:26-30.
38. Bartlett RH, Mault HR, Dechert RE, et al. Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure? Surgery 1986;100:400-8.
39. Davies SP, Reaveley DA, Brown EA, et al. Amino acid clearance and daily losses in patients with acute renal failure treated by continuous arteriovenous hemofiltration. In: Kramer P, editor. Arteriovenous hemofiltration. Berlin: Springer-Verlag; 1985. p. 139-51.
40. Davenport A, Roberts NB. Amino acid losses during continuous high-flux hemofiltration in the critically ill patient. Crit Care Med 1989;17:1010-4.
41. Mokrzycki MH, Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol 1996;7:2259-63.
42. Bellomo R, Tan HK, Bhonagiri S, et al. High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance. Int J Artif Organs 2002;25(4):263-8.
43. Payne-Jams JJ, Grimble GK. Present status of glutamine. Curr Opin Gastroenterol 1995;11:161-7.
44. Wilmore DW. Alterations in protein, carbohydrate and fat metabolism in injured and septic patients. J Am Coll Nutr 1983;2:3-13.
45. Georgieff M, Tvgtekin IF. Positive role of immune nutrition on metabolism in sepsis and multi-orgam failure. Kidney Int 1998;53(Suppl):S80-3.
46. Pastores SM, Kvetan V, Katz DP. Immunomodulatory effects and therapeutic potential of glutamine in the critically ill surgical patient. Nutrition 1994;10:365-91.
47. Golper TA. Drug removal during continuous renal replacement therapies. Dial Transplant 1993;22:185-212.
48. Reetze-Bonorden P, Bohler J, Keller E. Drug dosing in patients during continuous renal replacement therapy. Clin Pharmacokinit 1993;24:362-79.
49. Bressolli F, Kinowski JM, de la Coussaye JE, et al. Clinical pharmacokinetics during continuous hemofiltration. Clin Pharmacokinet 1994;26:457-71.
50. Schetz M, Ferdinade P, Van den Berghe G, et al. Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 1995;21:612-20.
51. Singlas E, Fillastre P. Pharmacokinetics of newer drugs in patients with renal impairment II. Clin Pharmoackinet 1991;20:389-419.
52. Kong K, Haynes S, Bion J, et al. Newer drugs in intensive care. Clin Anaesthesia 1990;4:305-31.
53. Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration and absorption in septic shock. Crit Care Med 2002;30:1250-5.
54. Fleming F, Bohn D, Edwards H, et al. Renal replacement therapy after repair of congenital heart disease in children. A comparison of hemofiltration and peritoneal dialysis. J Thorac Cardiovasc Surg 1995;109:322-31.
55. Zobel G, Ring E, Zobel V. Continuous arteriovenous renal replacement systems for critically ill children. Pediatr Nephrol 1989;3:140-3.
56. Symons JM, Brophy PD, Gregory MJ, et al. Continuous renal replacement therapy in pediatric patients weighing 10 kg or less [abstract]. Blood Purif 2002;20:306.